Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2018-09-24 Sale | 2018-09-25 6:00 pm | TESARO Inc. | TSRO | Huber Martin H. Jr. SVP & Chief Medical Officer | 371 | $37.63 | $13,961 | 13,456 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-02-02 Option Award | 2023-02-03 4:56 pm | N/A N/A | Syndax Pharmaceuticals Inc | SNDX | Huber Martin H. Jr. Director | 16,000 | $0 | 32,000 (Direct) | View |
| 2023-01-01 Option Award | 2023-01-04 4:11 pm | N/A 2032-12-31 | Xilio Therapeutics Inc. | XLO | Huber Martin H. Jr. PRESIDENT AND HEAD OF R&D | 136,500 | $0 | 136,500 (Direct) | View |
| 2022-06-15 Option Award(A) | 2022-06-23 7:30 pm | N/A 2032-06-14 | Xilio Therapeutics Inc. | XLO | Huber Martin H. Jr. PRESIDENT AND HEAD OF R&D | 20,000 | $0 | 20,000 (Direct) | View |
| 2022-06-15 Option Award | 2022-06-17 4:31 pm | N/A 2032-06-14 | Xilio Therapeutics Inc. | XLO | Huber Martin H. Jr. PRESIDENT AND HEAD OF R&D | 20,000 | $0 | 20,000 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-10 4:18 pm | N/A 2032-06-08 | Mersana Therapeutics Inc. | MRSN | Huber Martin H. Jr. Director | 45,000 | $0 | 45,000 (Direct) | View |
| 2022-02-22 Option Award | 2022-02-24 5:30 pm | N/A 2032-02-21 | Xilio Therapeutics Inc. | XLO | Huber Martin H. Jr. PRESIDENT OF R&D AND CMO | 65,000 | $0 | 65,000 (Direct) | View |
| 2022-02-02 Option Award | 2022-02-03 5:28 pm | N/A N/A | Syndax Pharmaceuticals Inc | SNDX | Huber Martin H. Jr. Director | 16,000 | $0 | 16,000 (Direct) | View |
| 2022-01-03 Option Award | 2022-01-05 5:05 pm | N/A 2032-01-02 | Mersana Therapeutics Inc. | MRSN | Huber Martin H. Jr. Director | 10,185 | $0 | 10,185 (Direct) | View |
| 2021-10-21 Option Award | 2021-10-25 5:17 pm | N/A 2031-10-20 | Xilio Therapeutics Inc. | XLO | Huber Martin H. Jr. President of R&D and CMO | 157,058 | $0 | 157,058 (Direct) | View |
Ownership | 2021-10-21 8:40 pm | N/A 2030-07-22 | Xilio Therapeutics Inc. | XLO | Huber Martin H. Jr. President of R&D and CMO | 0 | $0 | 291,855 (Direct) | View |
| 2021-09-15 Option Award | 2021-09-17 4:32 pm | N/A 2031-09-15 | Syndax Pharmaceuticals Inc | SNDX | Huber Martin H. Jr. Director | 35,000 | $19.36 | 35,000 (Direct) | View |
| 2021-06-11 Option Award | 2021-06-15 6:01 pm | N/A 2031-06-10 | Mersana Therapeutics Inc. | MRSN | Huber Martin H. Jr. Director | 25,050 | $0 | 25,050 (Direct) | View |
| 2021-01-15 Option Award | 2021-01-20 7:02 pm | N/A 2031-01-15 | Mersana Therapeutics Inc. | MRSN | Huber Martin H. Jr. Director | 2,490 | $0 | 2,490 (Direct) | View |
| 2020-04-13 Option Award | 2020-06-24 5:07 pm | N/A 2030-04-13 | Mersana Therapeutics Inc. | MRSN | Huber Martin H. Jr. Director | 48,096 | $0 | 48,096 (Direct) | View |
| 2019-01-22 Equity Swap | 2019-01-22 09:57 am | N/A N/A | TESARO Inc. | TSRO | Huber Martin H. Jr. SVP & Chief Medical Officer | 12,206 | $75 | 0 (Direct) | View |
| 2019-01-22 Disposition | 2019-01-22 09:57 am | N/A N/A | TESARO Inc. | TSRO | Huber Martin H. Jr. SVP & Chief Medical Officer | 197,898 | $0 | 0 (Direct) | View |
| 2018-09-21 Exercise | 2018-09-25 6:00 pm | N/A N/A | TESARO Inc. | TSRO | Huber Martin H. Jr. SVP & Chief Medical Officer | 1,250 | $0 | 13,456 (Direct) | View |